Inflammatory bio‐markers and cardiovascular risk prediction

By Blake Gj, P. Ridker. Journal of Internal Medicine, 2002

752 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

A systematic review and meta-analyses on C-reactive protein in relation to periodontitis. (2008, background): “The reason for the interest in plasma levels of CRP in periodontitis lies in the fact that epidemiological research indicates that periodontitis is associated with CVD.”
Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction. (2005, background): “Finally, sVCAM-1 was a predictor of a more advanced stage in the atherosclerotic process (25).”
[Guidelines on the management of stable angina pectoris: executive summary]. (2006, methodology): “Further laboratory testing, including cholesterol subfractions (ApoA and ApoB) homocysteine, lipoprotein (a) (Lpa), haemostatic abnormalities(20) and markers of inflammation such as hs C-reactive protein,(21) has been the subject of much interest as methods to improve current risk prediction.(21,22)”
Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. (2014, background): “cardiovascular diseases and death in the general population [20] and in patients with metabolic syndrome [21], an”